VJVybhav Jetty
Vybhav Jetty
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vybhav Jetty has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Charles Glueck
3 shared publications- Marloe Prince
HCA Houston Healthcare Kingwood Texas Cardiology Associates of Houston Kingwood Texas USA
3 shared publications - Parth Shah
Graduate Medical Education Department, Jewish Hospital of Cincinnati, Cincinnati, Ohio, USA.
3 shared publications Ping Wang
3 shared publications- Ashwin Kumar
Internal Medicine Residency Program, Cholesterol, Metabolism, and Thrombosis Center of the Jewish Hospital of Cincinnati, 2135 Dana Avenue, Suite 430, Cincinnati, OH 45207 USA
2 shared publications Kevin Lee
2 shared publications
Latest Publications
- 1 May 2017
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 11 (3) , 786
Eligibility for Alirocumab or Evolocumab Treatment in 1090 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center With LDL Cholesterol ≥70 Mg/Dl Despite Maximal Tolerated Cholesterol Lowering Therapy
- 1 May 2017
- Published by Elsevier in Journal of Clinical Lipidology
- Vol. 11 (3) , 786
Eligibility for Alirocumab or Evolocumab Treatment in 1090 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center With LDL Cholesterol ≥70 Mg/Dl Despite Maximal Tolerated Cholesterol Lowering Therapy
- Open Access
- 8 March 2016
- Published by Springer Nature in BMC Hematology
- Vol. 16 (1) , 1-7
Hospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia
- 8 March 2016
- Published by Springer Nature in BMC Hematology
- Vol. 16 (1) , 1-7
Open AccessHospitalization for pulmonary embolism associated with antecedent testosterone or estrogen therapy in patients found to have familial and acquired thrombophilia
- 1 February 2016
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 9 (4) , S61-S62
CRT-800.02 Eligibility for PCSK9 Treatment in 734 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center With Heterozygous Familial Hypercholesterolemia With LDL Cholesterol >100 Mg/dl and/or Atherosclerotic Cardiovascular Disease With LDL Cholesterol >70 Mg/dl Despite Maximal Tolerated Cholesterol Lowering Therapy
- 1 February 2016
- Published by Elsevier in JACC: Cardiovascular Interventions
- Vol. 9 (4) , S61-S62
CRT-800.02 Eligibility for PCSK9 Treatment in 734 Hypercholesterolemic Patients Referred to a Regional Cholesterol Treatment Center With Heterozygous Familial Hypercholesterolemia With LDL Cholesterol >100 Mg/dl and/or Atherosclerotic Cardiovascular Disease With LDL Cholesterol >70 Mg/dl Despite Maximal Tolerated Cholesterol Lowering Therapy